Lack of evidence for ribavirin monotherapy efficacy on liver fibrosis in hepatitis C virus positive renal transplant patients

Transplantation. 2005 Jun 27;79(12):1770-1; author reply 1771. doi: 10.1097/01.tp.0000158279.29506.e0.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • Hepatitis C / drug therapy*
  • Hepatitis C / surgery*
  • Humans
  • Kidney Transplantation* / pathology
  • Recurrence
  • Reproducibility of Results
  • Ribavirin / adverse effects*
  • Ribavirin / therapeutic use*

Substances

  • Antiviral Agents
  • Ribavirin